A large pocket structure surrounding the catalytic center in the BCG protein from Mycobacterium tuberculosis
Preprint
Abstract
The widespread prevalence of tuberculosis and the need for extensive chemotherapy in its treatment are caused by the ability of tuberculosis (TB) bacteria to enter a dormant state. Therefore, it is crucial to develop effective compounds that can inhibit the growth of TB bacteria in both the active and dormant states. Previous research has identified agelasine D (marine sponge-derived diterpene alkaloid) capable of resisting dormant mycobacteria. Additionally, BCG3185c has been designated as a target mycobacterial protein. In this study, the crystal structure of BCG3185c was determined at a resolution of 1.86 Å. Analysis of this crystal structure revealed a large pocket toward the catalytic center of BCG3185c, which is potentially adequate for agelasine D binding. Based on the results of the interaction analysis between agelasine D and Bacillus Calmette-Guérin (BCG) proteins, it was inferred that the binding of agelasine D to this large pocket is crucial for suppressing the growth of Mycobacterium tuberculosis .Keywords
This publication has 25 references indexed in Scilit:
- MicroScale Thermophoresis: Interaction analysis and beyondJournal of Molecular Structure, 2014
- Identification of the Target Protein of Agelasine D, a Marine Sponge Diterpene Alkaloid, as an Anti‐dormant Mycobacterial SubstanceChemBioChem, 2013
- Isolation and Structures of Axistatins 1–3 from the Republic of Palau Marine Sponge Agelas axifera HentschelJournal of Natural Products, 2013
- Neamphamide B, new cyclic depsipeptide, as an anti-dormant mycobacterial substance from a Japanese marine sponge of Neamphius sp.Bioorganic & Medicinal Chemistry Letters, 2012
- The marine sponge toxin agelasine B increases the intracellular Ca2+ concentration and induces apoptosis in human breast cancer cells (MCF-7)Cancer Chemotherapy and Pharmacology, 2011
- From anti-fouling to biofilm inhibition: New cytotoxic secondary metabolites from two Indonesian Agelas spongesBioorganic & Medicinal Chemistry, 2010
- Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agentBioorganic & Medicinal Chemistry, 2008
- Agelasines J, K, and L from the Solomon Islands Marine Sponge Agelas cf. mauritianaJournal of Natural Products, 2008
- (+)-Agelasine D: Improved Synthesis and Evaluation of Antibacterial and Cytotoxic ActivitiesJournal of Natural Products, 2006
- Agelasine-A, -B, -C and -D, novel bicyclic diterpenoids with a 9-methyladeninium unit possessing inhibitory effects on na,K-atpase from the okinawa sea sponge sp.1)Tetrahedron Letters, 1984